City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
August 15, 2017 | Katie Neith
City of Hope scientists in the Beckman Research Institute have received over $300,000 from The Leona M. and Harry B. Helmsley Charitable Trust to support scientific collaborations to fight type 1 diabetes.
July 14, 2017 | Travis Marshall
The idea of enlisting science and technology experts to present talks about their work for layman audiences is something Will Murdoch first encountered as an undergraduate.
July 13, 2017 | Abe Rosenberg
Joseph Gold, Ph.D., is chief overseer of a sprawling, state-of-the-art manufacturing facility cranking out mass quantities of carefully engineered stem cells aimed at curing the most dangerous and debilitating diseases of our time.
July 10, 2017 | City of Hope
Review the latest City of Hope grant awardees.
July 7, 2017 | Samantha Bonar
Graduate student Cai Roberts is exploring a novel twist on cancer treatment that targets a unique protein. The protein, called Twist, may allow cancer cells to take some devious turns within the body.
July 7, 2017 | Samantha Bonar
Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects.
July 6, 2017 | Katie Neith
At City of Hope, the Integrative Genomics Core (IGC) provides basic science, translational and clinical researchers with high-quality, efficient, comprehensive and cost-effective genomic services using microarray and high-throughput sequencing technologies.
July 6, 2017 | Samantha Bonar
Rick Kittles, Ph.D., has joined City of Hope as professor and founding director of the Division of Health Equities within the Department of Population Sciences. Kittles’ research focuses on understanding the complex issues surrounding race, genetic ancestry and disease, particularly health disparities among different ethnicities.
June 30, 2017 | Linda Malkas, Ph.D.
Henrietta Lacks certainly influenced my research, and continues to do so. Her impact is great here at City of Hope, as it is around the world. I’m just one scientist whose work has been made possible by Henrietta. There are many of us who owe her a profound debt of gratitude. Internationally, the number of people who have benefited from what she left behind is impossible to calculate.
June 29, 2017 | Katie Neith
Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.